SenesTech, Inc. (SNES) |
| 2.22 0.01 (0.45%) 02-26 09:31 |
| Open: | 2.14 |
| High: | 2.23 |
| Low: | 2.14 |
| Volume: | 950 |
| Market Cap: | 12(M) |
| PE Ratio: | -1 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Chemicals - Specialty |
| Sector: | Basic Materials |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.95 |
| Resistance 1: | 2.53 |
| Pivot price: | 2.05 |
| Support 1: | 1.97 |
| Support 2: | 1.62 |
| 52w High: | 6.24 |
| 52w Low: | 1.3 |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Financials
| EPS | -2.210 |
| Book Value | 2.170 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.280 |
| Profit Margin (%) | -253.54 |
| Operating Margin (%) | -195.22 |
| Return on Assets (ttm) | -38.5 |
| Return on Equity (ttm) | -77.8 |
Company news
Fri, 20 Feb 2026
Glenbrook Capital buys SenesTech (SNES) shares worth $200,634 By Investing.com - Investing.com Nigeria
Wed, 18 Feb 2026
Rat birth control bait cuts city tracking plate readings by 79–88% - Stock Titan
Tue, 10 Feb 2026
Non-lethal rat control maker brings Amazon sales in-house to lift margins - Stock Titan
Fri, 06 Feb 2026
Glenbrook Capital buys SenesTech (SNES) shares worth $15k - Investing.com UK
Mon, 02 Feb 2026
SenesTech's Evolve® Approved in New Zealand - ChartMill
Wed, 28 Jan 2026
Rodent-control firm SenesTech launches CEO search as chief plans exit - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
